Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366763 | 1.00 | GAA (0.58) | GAAMAPTTHRATHRBFYN | |
| SCHEMBL109159 | 1.00 | GAA (0.58) | GAAMAPTTHRATHRBFYN | |
| SCHEMBL29366853 | 1.00 | GAA (0.58) | GAAMAPTTHRATHRBFYN | |
| SCHEMBL12189700 | 1.00 | GAA (0.58) | GAAMAPTTHRATHRBFYN | |
| Hydrochloric Acid SCHEMBL2487322 | 0.98 | GAA (0.56) | GAAMAPTTHRATHRBFYN | |
| SCHEMBL13202969 | 0.80 | GAA (0.62) | GAAMAPTTHRATHRB | |
| SCHEMBL22462291 | 0.80 | MAPT (0.45) | GAAMAPTTHRATHRBEP300 | |
| SCHEMBL23996207 | 0.79 | GAA (0.56) | GAAMAPTTHRATHRB | |
| SCHEMBL8208975 | 0.79 | GAA (0.56) | GAAMAPT | |
| SCHEMBL27894459 | 0.79 | GAA (0.56) | GAAMAPTTHRATHRBEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210373358-A1 | UV-OVERPROTECTING IRIDESCENT COLORED CONTACT LENSES | THE UNIVERSITY OF AKRON | 2021-12-02 | — | — | US | disclosed |
| US-8703107-B2 | Cosmetic composition including leucodopachrome derivative | CHANEL PARFUMS BEAUTE (FR) | 2014-04-22 | — | — | US | disclosed |
| US-20120177588-A1 | COSMETIC COMPOSITION INCLUDING LEUCODOPACHROME DERIVATIVE | CHANEL PARFUMS BEAUTE (FR) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120177588-A1 | COSMETIC COMPOSITION INCLUDING LEUCODOPACHROME DERIVATIVE | TYR, LPO, DDT | GAA 661/4885MAPT 589/4885THRA 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.